+91 - 830 - 3146878
The purpose of this study was to evaluate the efficacy study of herbomineral drug LAS02 Capsule in Blood Cancer patients who were admitted in Lavanya Ayurvedic Hospital & Research Center For Cancer and AIDS. The study was conducted after getting ethical clearance. Total 14 patients of Blood Cancer. These patients were enrolled in Lavanaya hospital . These patients were suffering only from Blood Cancer not any other diseases. All patients having medication ayuredic herbomineral drug LAS02 Capsule for more than one month treatment. After obtaining prior consent form these patients, venous blood samples was collected from the subjects before and after treatment with herbomineral drug LAS02 Capsule and measured the hematological and biochemical examinations along with Blast Cell . A percentage levels (58.15% )of Blast Cell in Blood cancer patients were reduced in 14 treated patients as compared to before treated 14 patients . There was also significant reduced parentage level 26.26% ESR in patients after treatment with LAS02 Capsule more than one month as compared with before treatment. A significant reduction of hepatic enzymes (SGOT, SGPT, ALP ) in patients after treatment with drug. These findings suggested that LAS02 Capsule is most effective medicine for prevention Blood Cancer
Blood cancer is caused by malignancy that attacks the blood, lymphatic system, or bone marrow. There are three types:
Leukaemia affects your white blood cells. These are an important, infection-fighting part of your immune system, made in your bone marrow. If you have leukaemia, you produce an abnormal number of immature white blood cells which ‘clog up’ your bone marrow and stop it making other blood cells vital for a balanced immune system and healthy blood.
Lymphoma is a type of blood cancer that affects your lymphatic system, an important part of your immune system which helps to protect your body from infection and disease. If you have lymphoma it means you make too many lymphocytes, a type of white blood cell. Your lymphocytes also live longer than they should. This overload compromises your immune system. Lymphoma can develop in many parts of your body, including your lymph nodes, bone marrow, blood, spleen and other organs.
Myeloma (also called multiple myeloma) is a blood cancer of the plasma cells. Plasma cells are found in your bone marrow and produce antibodies which help fight infection. In myeloma, unusually large numbers of abnormal plasma cells gather in your bone marrow and stop it producing an important part of your immune system. In the UK, just under 4,800 people are diagnosed with myeloma each year. The risk of myeloma increases as you get older – about 4 out of 10 (40%) of cases are in people aged over 75.
The myelodysplastic syndromes (MDS) are a group of blood disorders where a person’s bone marrow is not producing the correct amount and quality of blood cells. Red, white and platelet cells can be affected.
These problems lead to people with MDS feeling very tired, weak and bleeding or bruising more easily.There are different levels of severity of MDS, it’s not a type of leukaemia but can sometimes lead to acute myeloid leukaemia. MDS is rare – about 4 in every 100,000 people get MDS. It mainly affects older people, and is more common in people over 70 years old.
If you have low or intermediate risk MDS you may not need treatment straightaway, but regular blood transfusions and medication can help. Some people with more severe MDS can have chemotherapy and a small number of people may need to have a stem cell transplant
A precursor cell, also called a blast cell or simply blast, is a type of partially differentiated, usually unipotent cell that has lost most or all of the stem cell multipotency.Usually a precursor cell is a stem cell which has the capacity to differentiate into only one cell types. Sometime sprecursor cell is used as an alternative term for unipotent stem cells.A blastoma is a type of cancer created by malignancies of precursor cells.In embryology, precursor cells are a group of cells that differentiate later into one organ.
The study was conducted after getting ethical clearance from Institutional human ethic committee. Total 14 blood cancer patients with age (7-65 years) were Lucknow city of Lavanya Ayurvedic Hospital and Research Center. These patients were only suffering from Blood Cancer not from any organic diseases. After obtaining prior consent form, venous blood samples was collected from the subjects before (pre) and after treatment (post) with herbomineral drug LAS02 Capsule under aseptic condition. The drug was given to these patients for two months. After collection of blood sample, serum and plasma were separated by centrifugation at 4000 rpm for 10 min. at room temperature for measurement of hematological, biochemical parameters along with in pre and post treated patients.
All hematological and biochemistry parameters hemoglobin (Hb), alkaline phosphate (ALP), Serum glutamate oxaloacetate transminase (SGOT), Serum glutamate pyurvate transminase (SGPT) parameters were measured by fully automatic cell counter and clinical chemistry analyzer.
LDH activity was measured by kit according to protocol provided by supplier (Tranasia biomedical). The activity was expressed as an IU/ml.
Resulting data were expressed mean ± SD. Percentage parenthesis was observed between pre vs post treatment with LAS02 drug in Ca-Blood patients.
There were reduction Percentage level of Blast cell in Blood caner 58.15% in patient Pre treated group is comparison to patient Post treated group and reduction. VIEW CHART
ESR level was also found in 26.26% decreased in the patients after treatment with LAS02 Capsule in comparison to pre treatment. VIEW CHART
There were slightly increased Hb(%), hematocrit and RBC levels in patient treated group as compared with patient pre treated group VIEW CHART
There were significant 23.2% and 13.26% reduction of TLC and ALP enzyme activities in Blood Cancer patients post treated group in comparison to patient pre treated group . VIEW CHART
On the basis of these findings it is suggested that the herbomineral drug LAS02 capsule is most effective and safe medicine for prevention of Blood Cancer inpatients.
The purpose of this study was to evaluate the acute oral toxicity study of LAS02 in female Sprague Dawley rat model. [...]
The purpose of this study was to evaluate the maximum tolerated dose of LAS02 in Sprague dawley female rat. [...]
The aim of this study was to evaluate the maximum tolerated dose of LAS02 in female Sprague Dawley rat. [...]